Clinical Trial Update: Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting completion of a study on a modified-process Hepatitis B vaccine in healthy neonates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Drugs mentioned

• Hepatitis B vaccine (modified-process) (Hepatitis B vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B, Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED